Identifying the needs for competency-based education in Europe: a needs assessment of cardiologists across 52 countries

J Eur CME. 2017 Jun 22;6(1):1337478. doi: 10.1080/21614083.2017.1337478. eCollection 2017.

Abstract

Objective: This international needs assessment was mandated by the European Society of Cardiology (ESC) to obtain an in-depth understanding of the current gaps and challenges of European cardiology professionals, with the aim to provide evidence for the development of needs-driven educational and professional development activities. Methods: This ethics-approved needs assessment was conducted among cardiologists from all sub-specialties across 56 countries of Europe and the Mediterranean basin. A mixed-methods research approach was used, combining qualitative in-depth interviews and focus groups with a quantitative survey. Results: Seventy-four (74) cardiologists participated in the qualitative phase and 866 completed the survey. Respondents represented 52 of the 56 targeted countries. Three themes were identified: 1) Challenges in the clinical decision-making process, 2) Challenges in establishing the patient-physician relationship, and 3) Sub-optimal team communication and collaboration. Specific gaps and causalities related to each challenge were found. Although most of the gaps were common across countries and sub-specialties, some significant differences were noted. Conclusion: The findings of this needs assessment indicate gaps and challenges in clinical practice across countries and across sub-specialities. Taking cardiology as an example, this study identifies clear areas of focus, especially around issues of collaboration and communication, for targeted competency-based education in Europe.

Keywords: European Society of Cardiology; cardiology; collaboration; communication; education; needs assessment; skills.

Grants and funding

This work was supported by unrestricted educational research funds from the European Society of Cardiology, using contributions from Daiichi Sankyo Europe GmbH, Servier International, AstraZeneca AB, Novartis Pharma AG, Bayer Pharma AG, Bristol-Myers Squibb / Pfizer.